1261P Efficacy of Glecirasib in Combination with JAB-3312 As a Front-Line Treatment for Patients with KRAS P.g12c Mutated NSCLC with PD-L1 Expression Levels or Co-Mutations

J. Wang, J. Zhao, J. Fang, Y. Yu, Q. Chu, X. Li, J. Chen, Z. Liu, L. Zhang, L. Wu,W. Zhuang, Y. Zhao,L. Xing, L. Liu,C. Bai, X. Dong, Q. Song, R. Wan, X. Fang

Annals of Oncology（2024）

引用 0|浏览1